Global Overactive Bladder Diagnosis and Treatment Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Overactive Bladder Diagnosis and Treatment Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Overactive Bladder Diagnosis and Treatment by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Overactive Bladder Diagnosis and Treatment by Country/Region, 2017, 2022 & 2028

2.2 Overactive Bladder Diagnosis and Treatment Segment by Type

2.2.1 Anticholinergics

2.2.2 Mirabegron

2.2.3 BOTOX

2.2.4 Neuromodulation

2.2.5 Others

2.3 Overactive Bladder Diagnosis and Treatment Sales by Type

2.3.1 Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

2.3.2 Global Overactive Bladder Diagnosis and Treatment Revenue and Market Share by Type (2017-2022)

2.3.3 Global Overactive Bladder Diagnosis and Treatment Sale Price by Type (2017-2022)

2.4 Overactive Bladder Diagnosis and Treatment Segment by Application

2.4.1 Idiopathic Overactive Bladder

2.4.2 Neurogenic Overactive Bladder

2.5 Overactive Bladder Diagnosis and Treatment Sales by Application

2.5.1 Global Overactive Bladder Diagnosis and Treatment Sale Market Share by Application (2017-2022)

2.5.2 Global Overactive Bladder Diagnosis and Treatment Revenue and Market Share by Application (2017-2022)

2.5.3 Global Overactive Bladder Diagnosis and Treatment Sale Price by Application (2017-2022)

3 Global Overactive Bladder Diagnosis and Treatment by Company

3.1 Global Overactive Bladder Diagnosis and Treatment Breakdown Data by Company

3.1.1 Global Overactive Bladder Diagnosis and Treatment Annual Sales by Company (2020-2022)

3.1.2 Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Company (2020-2022)

3.2 Global Overactive Bladder Diagnosis and Treatment Annual Revenue by Company (2020-2022)

3.2.1 Global Overactive Bladder Diagnosis and Treatment Revenue by Company (2020-2022)

3.2.2 Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Company (2020-2022)

3.3 Global Overactive Bladder Diagnosis and Treatment Sale Price by Company

3.4 Key Manufacturers Overactive Bladder Diagnosis and Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Overactive Bladder Diagnosis and Treatment Product Location Distribution

3.4.2 Players Overactive Bladder Diagnosis and Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Overactive Bladder Diagnosis and Treatment by Geographic Region

4.1 World Historic Overactive Bladder Diagnosis and Treatment Market Size by Geographic Region (2017-2022)

4.1.1 Global Overactive Bladder Diagnosis and Treatment Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Overactive Bladder Diagnosis and Treatment Annual Revenue by Geographic Region

4.2 World Historic Overactive Bladder Diagnosis and Treatment Market Size by Country/Region (2017-2022)

4.2.1 Global Overactive Bladder Diagnosis and Treatment Annual Sales by Country/Region (2017-2022)

4.2.2 Global Overactive Bladder Diagnosis and Treatment Annual Revenue by Country/Region

4.3 Americas Overactive Bladder Diagnosis and Treatment Sales Growth

4.4 APAC Overactive Bladder Diagnosis and Treatment Sales Growth

4.5 Europe Overactive Bladder Diagnosis and Treatment Sales Growth

4.6 Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Growth

5 Americas

5.1 Americas Overactive Bladder Diagnosis and Treatment Sales by Country

5.1.1 Americas Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022)

5.1.2 Americas Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022)

5.2 Americas Overactive Bladder Diagnosis and Treatment Sales by Type

5.3 Americas Overactive Bladder Diagnosis and Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Overactive Bladder Diagnosis and Treatment Sales by Region

6.1.1 APAC Overactive Bladder Diagnosis and Treatment Sales by Region (2017-2022)

6.1.2 APAC Overactive Bladder Diagnosis and Treatment Revenue by Region (2017-2022)

6.2 APAC Overactive Bladder Diagnosis and Treatment Sales by Type

6.3 APAC Overactive Bladder Diagnosis and Treatment Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Overactive Bladder Diagnosis and Treatment by Country

7.1.1 Europe Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022)

7.1.2 Europe Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022)

7.2 Europe Overactive Bladder Diagnosis and Treatment Sales by Type

7.3 Europe Overactive Bladder Diagnosis and Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Overactive Bladder Diagnosis and Treatment by Country

8.1.1 Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022)

8.1.2 Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022)

8.2 Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Type

8.3 Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Overactive Bladder Diagnosis and Treatment

10.3 Manufacturing Process Analysis of Overactive Bladder Diagnosis and Treatment

10.4 Industry Chain Structure of Overactive Bladder Diagnosis and Treatment

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Overactive Bladder Diagnosis and Treatment Distributors

11.3 Overactive Bladder Diagnosis and Treatment Customer

12 World Forecast Review for Overactive Bladder Diagnosis and Treatment by Geographic Region

12.1 Global Overactive Bladder Diagnosis and Treatment Market Size Forecast by Region

12.1.1 Global Overactive Bladder Diagnosis and Treatment Forecast by Region (2023-2028)

12.1.2 Global Overactive Bladder Diagnosis and Treatment Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Overactive Bladder Diagnosis and Treatment Forecast by Type

12.7 Global Overactive Bladder Diagnosis and Treatment Forecast by Application

13 Key Players Analysis

13.1 Astellas Pharma Inc

13.1.1 Astellas Pharma Inc Company Information

13.1.2 Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Product Offered

13.1.3 Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astellas Pharma Inc Main Business Overview

13.1.5 Astellas Pharma Inc Latest Developments

13.2 Teva Pharmaceutical Industries

13.2.1 Teva Pharmaceutical Industries Company Information

13.2.2 Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product Offered

13.2.3 Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Pharmaceutical Industries Main Business Overview

13.2.5 Teva Pharmaceutical Industries Latest Developments

13.3 Pfizer Inc

13.3.1 Pfizer Inc Company Information

13.3.2 Pfizer Inc Overactive Bladder Diagnosis and Treatment Product Offered

13.3.3 Pfizer Inc Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Inc Main Business Overview

13.3.5 Pfizer Inc Latest Developments

13.4 Abbvie Inc

13.4.1 Abbvie Inc Company Information

13.4.2 Abbvie Inc Overactive Bladder Diagnosis and Treatment Product Offered

13.4.3 Abbvie Inc Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbvie Inc Main Business Overview

13.4.5 Abbvie Inc Latest Developments

13.5 Viatris Inc

13.5.1 Viatris Inc Company Information

13.5.2 Viatris Inc Overactive Bladder Diagnosis and Treatment Product Offered

13.5.3 Viatris Inc Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Viatris Inc Main Business Overview

13.5.5 Viatris Inc Latest Developments

13.6 Hisamitsu Pharmaceutical

13.6.1 Hisamitsu Pharmaceutical Company Information

13.6.2 Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Product Offered

13.6.3 Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hisamitsu Pharmaceutical Main Business Overview

13.6.5 Hisamitsu Pharmaceutical Latest Developments

13.7 Johnson & Johnson Services

13.7.1 Johnson & Johnson Services Company Information

13.7.2 Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Product Offered

13.7.3 Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson & Johnson Services Main Business Overview

13.7.5 Johnson & Johnson Services Latest Developments

13.8 Endo Pharmaceuticals

13.8.1 Endo Pharmaceuticals Company Information

13.8.2 Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

13.8.3 Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Endo Pharmaceuticals Main Business Overview

13.8.5 Endo Pharmaceuticals Latest Developments

13.9 Lupin

13.9.1 Lupin Company Information

13.9.2 Lupin Overactive Bladder Diagnosis and Treatment Product Offered

13.9.3 Lupin Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Lupin Main Business Overview

13.9.5 Lupin Latest Developments

13.10 KYORIN Pharmaceutical

13.10.1 KYORIN Pharmaceutical Company Information

13.10.2 KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Product Offered

13.10.3 KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 KYORIN Pharmaceutical Main Business Overview

13.10.5 KYORIN Pharmaceutical Latest Developments

13.11 Amneal Pharmaceuticals

13.11.1 Amneal Pharmaceuticals Company Information

13.11.2 Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

13.11.3 Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Amneal Pharmaceuticals Main Business Overview

13.11.5 Amneal Pharmaceuticals Latest Developments

13.12 Sun Pharmaceutical Industries

13.12.1 Sun Pharmaceutical Industries Company Information

13.12.2 Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product Offered

13.12.3 Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sun Pharmaceutical Industries Main Business Overview

13.12.5 Sun Pharmaceutical Industries Latest Developments

13.13 Glenmark

13.13.1 Glenmark Company Information

13.13.2 Glenmark Overactive Bladder Diagnosis and Treatment Product Offered

13.13.3 Glenmark Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Glenmark Main Business Overview

13.13.5 Glenmark Latest Developments

13.14 Macleods Pharmaceuticals

13.14.1 Macleods Pharmaceuticals Company Information

13.14.2 Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

13.14.3 Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Macleods Pharmaceuticals Main Business Overview

13.14.5 Macleods Pharmaceuticals Latest Developments

13.15 Medtronic

13.15.1 Medtronic Company Information

13.15.2 Medtronic Overactive Bladder Diagnosis and Treatment Product Offered

13.15.3 Medtronic Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Medtronic Main Business Overview

13.15.5 Medtronic Latest Developments

13.16 Ajanta Pharma

13.16.1 Ajanta Pharma Company Information

13.16.2 Ajanta Pharma Overactive Bladder Diagnosis and Treatment Product Offered

13.16.3 Ajanta Pharma Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Ajanta Pharma Main Business Overview

13.16.5 Ajanta Pharma Latest Developments

13.17 Granules India

13.17.1 Granules India Company Information

13.17.2 Granules India Overactive Bladder Diagnosis and Treatment Product Offered

13.17.3 Granules India Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Granules India Main Business Overview

13.17.5 Granules India Latest Developments

13.18 Urovant Sciences

13.18.1 Urovant Sciences Company Information

13.18.2 Urovant Sciences Overactive Bladder Diagnosis and Treatment Product Offered

13.18.3 Urovant Sciences Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Urovant Sciences Main Business Overview

13.18.5 Urovant Sciences Latest Developments

13.19 Apotex Inc.

13.19.1 Apotex Inc. Company Information

13.19.2 Apotex Inc. Overactive Bladder Diagnosis and Treatment Product Offered

13.19.3 Apotex Inc. Overactive Bladder Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Apotex Inc. Main Business Overview

13.19.5 Apotex Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Overactive Bladder Diagnosis and Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Overactive Bladder Diagnosis and Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Anticholinergics

Table 4. Major Players of Mirabegron

Table 5. Major Players of BOTOX

Table 6. Major Players of Neuromodulation

Table 7. Major Players of Others

Table 8. Global Overactive Bladder Diagnosis and Treatment Sales by Type (2017-2022) & (K Units)

Table 9. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

Table 10. Global Overactive Bladder Diagnosis and Treatment Revenue by Type (2017-2022) & ($ million)

Table 11. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Type (2017-2022)

Table 12. Global Overactive Bladder Diagnosis and Treatment Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Overactive Bladder Diagnosis and Treatment Sales by Application (2017-2022) & (K Units)

Table 14. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Table 15. Global Overactive Bladder Diagnosis and Treatment Revenue by Application (2017-2022)

Table 16. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Application (2017-2022)

Table 17. Global Overactive Bladder Diagnosis and Treatment Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Overactive Bladder Diagnosis and Treatment Sales by Company (2020-2022) & (K Units)

Table 19. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Company (2020-2022)

Table 20. Global Overactive Bladder Diagnosis and Treatment Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Company (2020-2022)

Table 22. Global Overactive Bladder Diagnosis and Treatment Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Overactive Bladder Diagnosis and Treatment Producing Area Distribution and Sales Area

Table 24. Players Overactive Bladder Diagnosis and Treatment Products Offered

Table 25. Overactive Bladder Diagnosis and Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Overactive Bladder Diagnosis and Treatment Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Overactive Bladder Diagnosis and Treatment Sales Market Share Geographic Region (2017-2022)

Table 30. Global Overactive Bladder Diagnosis and Treatment Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Overactive Bladder Diagnosis and Treatment Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Country/Region (2017-2022)

Table 34. Global Overactive Bladder Diagnosis and Treatment Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022) & (K Units)

Table 37. Americas Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2017-2022)

Table 38. Americas Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2017-2022)

Table 40. Americas Overactive Bladder Diagnosis and Treatment Sales by Type (2017-2022) & (K Units)

Table 41. Americas Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

Table 42. Americas Overactive Bladder Diagnosis and Treatment Sales by Application (2017-2022) & (K Units)

Table 43. Americas Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Table 44. APAC Overactive Bladder Diagnosis and Treatment Sales by Region (2017-2022) & (K Units)

Table 45. APAC Overactive Bladder Diagnosis and Treatment Sales Market Share by Region (2017-2022)

Table 46. APAC Overactive Bladder Diagnosis and Treatment Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Overactive Bladder Diagnosis and Treatment Revenue Market Share by Region (2017-2022)

Table 48. APAC Overactive Bladder Diagnosis and Treatment Sales by Type (2017-2022) & (K Units)

Table 49. APAC Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

Table 50. APAC Overactive Bladder Diagnosis and Treatment Sales by Application (2017-2022) & (K Units)

Table 51. APAC Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Table 52. Europe Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022) & (K Units)

Table 53. Europe Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2017-2022)

Table 54. Europe Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2017-2022)

Table 56. Europe Overactive Bladder Diagnosis and Treatment Sales by Type (2017-2022) & (K Units)

Table 57. Europe Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

Table 58. Europe Overactive Bladder Diagnosis and Treatment Sales by Application (2017-2022) & (K Units)

Table 59. Europe Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Overactive Bladder Diagnosis and Treatment

Table 69. Key Market Challenges & Risks of Overactive Bladder Diagnosis and Treatment

Table 70. Key Industry Trends of Overactive Bladder Diagnosis and Treatment

Table 71. Overactive Bladder Diagnosis and Treatment Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Overactive Bladder Diagnosis and Treatment Distributors List

Table 74. Overactive Bladder Diagnosis and Treatment Customer List

Table 75. Global Overactive Bladder Diagnosis and Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Overactive Bladder Diagnosis and Treatment Sales Market Forecast by Region

Table 77. Global Overactive Bladder Diagnosis and Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Overactive Bladder Diagnosis and Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Overactive Bladder Diagnosis and Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Overactive Bladder Diagnosis and Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Overactive Bladder Diagnosis and Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Overactive Bladder Diagnosis and Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Overactive Bladder Diagnosis and Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Overactive Bladder Diagnosis and Treatment Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Overactive Bladder Diagnosis and Treatment Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Overactive Bladder Diagnosis and Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Overactive Bladder Diagnosis and Treatment Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Overactive Bladder Diagnosis and Treatment Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Overactive Bladder Diagnosis and Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share Forecast by Application (2023-2028)

Table 95. Astellas Pharma Inc Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 96. Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Product Offered

Table 97. Astellas Pharma Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Astellas Pharma Inc Main Business

Table 99. Astellas Pharma Inc Latest Developments

Table 100. Teva Pharmaceutical Industries Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 101. Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product Offered

Table 102. Teva Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Teva Pharmaceutical Industries Main Business

Table 104. Teva Pharmaceutical Industries Latest Developments

Table 105. Pfizer Inc Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 106. Pfizer Inc Overactive Bladder Diagnosis and Treatment Product Offered

Table 107. Pfizer Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Pfizer Inc Main Business

Table 109. Pfizer Inc Latest Developments

Table 110. Abbvie Inc Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 111. Abbvie Inc Overactive Bladder Diagnosis and Treatment Product Offered

Table 112. Abbvie Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Abbvie Inc Main Business

Table 114. Abbvie Inc Latest Developments

Table 115. Viatris Inc Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 116. Viatris Inc Overactive Bladder Diagnosis and Treatment Product Offered

Table 117. Viatris Inc Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Viatris Inc Main Business

Table 119. Viatris Inc Latest Developments

Table 120. Hisamitsu Pharmaceutical Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 121. Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Product Offered

Table 122. Hisamitsu Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Hisamitsu Pharmaceutical Main Business

Table 124. Hisamitsu Pharmaceutical Latest Developments

Table 125. Johnson & Johnson Services Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 126. Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Product Offered

Table 127. Johnson & Johnson Services Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Johnson & Johnson Services Main Business

Table 129. Johnson & Johnson Services Latest Developments

Table 130. Endo Pharmaceuticals Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 131. Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

Table 132. Endo Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Endo Pharmaceuticals Main Business

Table 134. Endo Pharmaceuticals Latest Developments

Table 135. Lupin Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 136. Lupin Overactive Bladder Diagnosis and Treatment Product Offered

Table 137. Lupin Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Lupin Main Business

Table 139. Lupin Latest Developments

Table 140. KYORIN Pharmaceutical Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 141. KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Product Offered

Table 142. KYORIN Pharmaceutical Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. KYORIN Pharmaceutical Main Business

Table 144. KYORIN Pharmaceutical Latest Developments

Table 145. Amneal Pharmaceuticals Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 146. Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

Table 147. Amneal Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Amneal Pharmaceuticals Main Business

Table 149. Amneal Pharmaceuticals Latest Developments

Table 150. Sun Pharmaceutical Industries Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 151. Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Product Offered

Table 152. Sun Pharmaceutical Industries Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Sun Pharmaceutical Industries Main Business

Table 154. Sun Pharmaceutical Industries Latest Developments

Table 155. Glenmark Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 156. Glenmark Overactive Bladder Diagnosis and Treatment Product Offered

Table 157. Glenmark Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Glenmark Main Business

Table 159. Glenmark Latest Developments

Table 160. Macleods Pharmaceuticals Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 161. Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Product Offered

Table 162. Macleods Pharmaceuticals Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Macleods Pharmaceuticals Main Business

Table 164. Macleods Pharmaceuticals Latest Developments

Table 165. Medtronic Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 166. Medtronic Overactive Bladder Diagnosis and Treatment Product Offered

Table 167. Medtronic Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Medtronic Main Business

Table 169. Medtronic Latest Developments

Table 170. Ajanta Pharma Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 171. Ajanta Pharma Overactive Bladder Diagnosis and Treatment Product Offered

Table 172. Ajanta Pharma Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 173. Ajanta Pharma Main Business

Table 174. Ajanta Pharma Latest Developments

Table 175. Granules India Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 176. Granules India Overactive Bladder Diagnosis and Treatment Product Offered

Table 177. Granules India Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 178. Granules India Main Business

Table 179. Granules India Latest Developments

Table 180. Urovant Sciences Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 181. Urovant Sciences Overactive Bladder Diagnosis and Treatment Product Offered

Table 182. Urovant Sciences Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 183. Urovant Sciences Main Business

Table 184. Urovant Sciences Latest Developments

Table 185. Apotex Inc. Basic Information, Overactive Bladder Diagnosis and Treatment Manufacturing Base, Sales Area and Its Competitors

Table 186. Apotex Inc. Overactive Bladder Diagnosis and Treatment Product Offered

Table 187. Apotex Inc. Overactive Bladder Diagnosis and Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 188. Apotex Inc. Main Business

Table 189. Apotex Inc. Latest Developments

List of Figures

Figure 1. Picture of Overactive Bladder Diagnosis and Treatment

Figure 2. Overactive Bladder Diagnosis and Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Overactive Bladder Diagnosis and Treatment Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Overactive Bladder Diagnosis and Treatment Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Overactive Bladder Diagnosis and Treatment Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Anticholinergics

Figure 10. Product Picture of Mirabegron

Figure 11. Product Picture of BOTOX

Figure 12. Product Picture of Neuromodulation

Figure 13. Product Picture of Others

Figure 14. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Type in 2021

Figure 15. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Type (2017-2022)

Figure 16. Overactive Bladder Diagnosis and Treatment Consumed in Idiopathic Overactive Bladder

Figure 17. Global Overactive Bladder Diagnosis and Treatment Market: Idiopathic Overactive Bladder (2017-2022) & (K Units)

Figure 18. Overactive Bladder Diagnosis and Treatment Consumed in Neurogenic Overactive Bladder

Figure 19. Global Overactive Bladder Diagnosis and Treatment Market: Neurogenic Overactive Bladder (2017-2022) & (K Units)

Figure 20. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Application (2017-2022)

Figure 21. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Application in 2021

Figure 22. Overactive Bladder Diagnosis and Treatment Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Company in 2021

Figure 24. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Geographic Region in 2021

Figure 26. Global Overactive Bladder Diagnosis and Treatment Sales Market Share by Region (2017-2022)

Figure 27. Global Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country/Region in 2021

Figure 28. Americas Overactive Bladder Diagnosis and Treatment Sales 2017-2022 (K Units)

Figure 29. Americas Overactive Bladder Diagnosis and Treatment Revenue 2017-2022 ($ Millions)

Figure 30. APAC Overactive Bladder Diagnosis and Treatment Sales 2017-2022 (K Units)

Figure 31. APAC Overactive Bladder Diagnosis and Treatment Revenue 2017-2022 ($ Millions)

Figure 32. Europe Overactive Bladder Diagnosis and Treatment Sales 2017-2022 (K Units)

Figure 33. Europe Overactive Bladder Diagnosis and Treatment Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue 2017-2022 ($ Millions)

Figure 36. Americas Overactive Bladder Diagnosis and Treatment Sales Market Share by Country in 2021

Figure 37. Americas Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country in 2021

Figure 38. United States Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Overactive Bladder Diagnosis and Treatment Sales Market Share by Region in 2021

Figure 43. APAC Overactive Bladder Diagnosis and Treatment Revenue Market Share by Regions in 2021

Figure 44. China Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Overactive Bladder Diagnosis and Treatment Sales Market Share by Country in 2021

Figure 51. Europe Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country in 2021

Figure 52. Germany Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Overactive Bladder Diagnosis and Treatment Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Overactive Bladder Diagnosis and Treatment Revenue Market Share by Country in 2021

Figure 59. Egypt Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Overactive Bladder Diagnosis and Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Overactive Bladder Diagnosis and Treatment in 2021

Figure 65. Manufacturing Process Analysis of Overactive Bladder Diagnosis and Treatment

Figure 66. Industry Chain Structure of Overactive Bladder Diagnosis and Treatment

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles